Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma
Anticancer Research · 2025
DOI: 10.21873/anticanres.17450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Ioannis G Gkionis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Venizeleio General Hospital, Heraklion, Greece. Hauptthemen laut MEDLINE: Melanoma, Cyclin E, Biomarkers, Tumor, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Venizeleio General Hospital, Heraklion, Greece.
- School of Medicine, University of Crete, Heraklion, Greece.
- Department of Pathology, University Hospital of Heraklion, Heraklion, Greece.
- Department of Surgical Oncology, University Hospital of Heraklion, Heraklion, Greece.
- Department of Dermatology, University Hospital of Heraklion, Heraklion, Greece.
- School of Medicine, University of Crete, Heraklion, Greece debree@uoc.gr.
Zitieren
APA
Gkionis, I. G., Tzardi, M., Alegakis, A., Datseri, G., Moustou, E., Saridakis, G., Michelakis, D., Kruger-Krasagakis, S., Krasagakis, K., & DE Bree, E. (2025). Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma. Anticancer Research. https://doi.org/10.21873/anticanres.17450
Vancouver
Gkionis IG, Tzardi M, Alegakis A, Datseri G, Moustou E, Saridakis G, et al. Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma. Anticancer Research. 2025. doi:10.21873/anticanres.17450
BibTeX
@article{Gkionis2025,
author = {Gkionis, Ioannis G and Tzardi, Maria and Alegakis, Athanasios and Datseri, Galateia and Moustou, Eleni and Saridakis, Georgios and Michelakis, Dimosthenis and Kruger-Krasagakis, Sabine and Krasagakis, Konstantinos and DE Bree, Eelco},
title = {Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17450}
}
EUVIMED